Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | MAPT | P10636 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552201 | 0.95 | AKT1 (0.33) | AKT1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8682472 | 0.89 | HDAC3 (0.37) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL461687 | 0.84 | MAPT (0.37) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL16147696 | 0.81 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL2729308 | 0.77 | HDAC3 (0.33) | AKT1HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18833161 | 0.77 | AKT1 (0.39) | AKT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL4657359 | 0.75 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL17746649 | 0.75 | LMNA (0.39) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL9362014 | 0.74 | ALDH1A1 (0.41) | AKT1ALDH1A1MAPTKMT2ALMNA | |
| SCHEMBL624043 | 0.72 | GLA (0.41) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 926 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124747-A1 | THERMAL BONDING FILM, METHOD FOR PRODUCING SAME, AND WATER TANK ADHESION STRUCTURE USING SAME FOR AIR-TO-WATER SOURCE HEAT PUMP | LG ELECTRONICS INC. (KR) | 2024-04-18 | — | — | US | claimed |
| EP-4293068-A1 | THERMAL BONDING FILM, METHOD FOR PRODUCING SAME, AND WATER TANK ADHESION STRUCTURE USING SAME FOR AIR-TO-WATER SOURCE HEAT PUMP | LG Electronics Inc. (KR) | 2023-12-20 | — | — | EP | claimed |
| US-11331939-B2 | Recording media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-05-17 | — | — | US | claimed |
| US-20200301296-A1 | EMULSION AGGREGATION PROCESS | XEROX CORPORATION | 2020-09-24 | — | — | US | claimed |
| US-20200180338-A1 | RECORDING MEDIA | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2020-06-11 | — | — | US | claimed |
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | claimed |
| US-10570290-B2 | Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins | XEROX CORPORATION (US) | 2020-02-25 | — | — | US | claimed |
| US-10543707-B2 | Recording media | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-01-28 | — | — | US | claimed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | claimed |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | XEROX CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-5965316-A | Wax processes | XEROX CORPORATION (US) | 1999-10-12 | — | — | US | claimed |
| US-5928832-A | Toner adsorption processes | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5928830-A | Latex processes | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0928994-A2 | Toner preparation processes | Xerox Corporation (US) | 1999-07-14 | — | — | EP | claimed |
| US-5910387-A | Toner compositions with acrylonitrile and processes | XEROX CORPORATION (US) | 1999-06-08 | — | — | US | claimed |
| US-5869216-A | LATEX, AGGREGATION, FUSION/COALESCENCE, SURFACE TREATMENT WITH A SALICYLIC ACID OR A CATECHOL | XEROX CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| US-5863698-A | MIXING COLORANT COMPRISING PHOSPHATE-CONTAINING SURFACTANT, LATEX EMULSION, HEATING, STABILIZING | XEROX CORPORATION (US) | 1999-01-26 | — | — | US | claimed |
| US-5827633-A | Toner processes | XEROX CORPORATION (US) | 1998-10-27 | — | — | US | claimed |
| US-5766818-A | Toner processes with hydrolyzable surfactant | XEROX CORPORATION (US) | 1998-06-16 | — | — | US | claimed |
| US-5766817-A | AGGREGATING COLORANT DISPERSION WITH LATEX MINIEMULSION CONTAINING POLYMER AND IONIC AND NONIONIC SURFACTANTS, COALESCING THE AGGREGATES GENERATED | XEROX CORPORATION (US) | 1998-06-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | TERB1, NBAS, MFAP1 | AKT1 4203/4885HDAC3 2641/4885HDAC4 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.